Enzo Biochem (ENZ) Presents New AmpiProbeā„¢ Nucleic Acid Amplification Platform Details at ESCMID London Meeting  
4/2/2012 10:34:20 AM

EW YORK--(BUSINESS WIRE)--Enzo Biochem Inc. (NYSE:ENZ) announced that the Company yesterday made its first peer-reviewed presentation of its novel AmpiProbeā„¢ platform, encompassing low cost, and high sensitivity, real time nucleic acid amplification and detection assays, at the annual meeting in London of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).